Leveraging real-world data to predict cancer cachexia stage, quality of life, and survival in a racially and ethnically diverse multi-institutional cohort of treatment-naïve patients with pancreatic ductal adenocarcinoma.

Autor: Permuth JB; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, United States.; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, United States., Park MA; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, United States.; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, United States., Chen DT; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, United States., Basinski T; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, United States., Powers BD; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, United States.; Department of Surgery, School of Medicine, University of Maryland, Baltimore, MD, United States., Gwede CK; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, United States., Dezsi KB; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, United States., Gomez M; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, United States.; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, United States., Vyas SL; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, United States.; Research Analytics and Development Cores, Baylor Scott & White Research Institute (BSWRI), Dallas, TX, United States., Biachi T; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, United States., Cortizas EM; Leonard M. Miller School of Medicine, University of Miami, Miami, FL, United States., Crowder S; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, United States., Genilo-Delgado M; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, United States., Green BL; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, United States., Greene A; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, United States., Gregg C; Department of Neurobiology, School of Medicine, University of Utah Health, Salt Lake City, UT, United States., Hoffe SE; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, United States., Jiang K; Department of Pathology, Moffitt Cancer Center, Tampa, FL, United States., Kim B; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, United States., Vasudevan V; Center for Advanced Surgical Oncology, Palmetto General Hospital, Hialeah, FL, United States., Garcialopez De Llano J; Center for Advanced Surgical Oncology, Palmetto General Hospital, Hialeah, FL, United States., Menon AA; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, United States., Mo Q; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, United States., MorenoUrazan LM; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, United States., Mok S; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, United States., Parker N; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, United States., Rajasekhara S; Supportive Care Medicine, Moffitt Cancer Center, Tampa, FL, United States., Rasool G; Department of Machine Learning, Moffitt Cancer Center, Tampa, FL, United States., Sinnamon A; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, United States., Sparks L; Translational Research Institute, AdventHealth, Orlando, FL, United States., Stewart PA; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, United States., Tardif K; Department of Surgery, St. Anthony's Hospital, St. Petersburg, FL, United States., Tassielli AF; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, United States., Teer JK; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, United States., Tran DV; Leonard M. Miller School of Medicine, University of Miami, Miami, FL, United States., Turner KL; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, United States., Vadaparampil ST; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, United States.; Community Outreach, Engagement & Equity, Moffitt Cancer Center, Tampa, FL, United States., Whelan CJ; Department of Metabolism and Cancer Physiology, Moffitt Cancer Center, Tampa, FL, United States., Douglas WG; Department of Clinical Sciences, College of Medicine, Florida State University, Tallahassee, FL, United States., Velanovich V; Tampa General Hospital, Tampa, FL, United States., Karachristos A; Tampa General Hospital, Tampa, FL, United States., Legaspi A; Center for Advanced Surgical Oncology, Palmetto General Hospital, Hialeah, FL, United States., Meredith K; Department of Gastrointestinal Surgical Oncology, Sarasota Memorial Hospital, Sarasota, FL, United States., Molina-Vega MA; Department of Surgical Oncology, Lakeland Regional Hospital, Lakeland, FL, United States., Huguet KL; Department of Surgery, St. Anthony's Hospital, St. Petersburg, FL, United States., Arnoletti JP; Department of Surgical Oncology, Orlando Regional Medical Center, Orlando, FL, United States., Bloomston M; Department of Surgical Oncology, Lee Health Regional Cancer Center, Fort Myers, FL, United States., Trevino J; Department of Surgery, College of Medicine, University of Florida, Gainesville, FL, United States.; Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, United States., Merchant NB; Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, United States., Pimiento JM; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, United States., Hodul PJ; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, United States., Malafa M; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, United States., Fleming J; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, United States., Judge SM; Department of Physical Therapy, College of Public Health and Health Professions, University of Florida, Gainesville, FL, United States., Jeong DK; Supportive Care Medicine, Moffitt Cancer Center, Tampa, FL, United States., Judge A; Department of Physical Therapy, College of Public Health and Health Professions, University of Florida, Gainesville, FL, United States.

Publikováno v: Frontiers in oncology [Front Oncol] 2024 Jul 23; Vol. 14, pp. 1362244. Date of Electronic Publication: 2024 Jul 23 (Print Publication: 2024).

Improving Operating Room Efficiency: Relocating a Surgical Oncology Program Within a Health Care System.

Autor: Orr JW; Lee Health Regional Cancer Center, Fort Myers, FL.; GenesisCare USA, Fort Myers, FL., Thompson AM; Lee Health Regional Cancer Center, Fort Myers, FL., Bruens D; GenesisCare USA, Fort Myers, FL., Higgins J; Lee Health Regional Cancer Center, Fort Myers, FL., Rittenhouse Y; Lee Health Regional Cancer Center, Fort Myers, FL., Bloomston M; GenesisCare USA, Fort Myers, FL., Riker AI; GenesisCare USA, Fort Myers, FL.

Publikováno v: Ochsner journal [Ochsner J] 2022 Fall; Vol. 22 (3), pp. 230-238.

Surgeon experience contributes to improved outcomes in pancreatoduodenectomies at high risk for fistula development

Autor: Casciani, F., Trudeau, M., Asbun, H., Ball, C., Bassi, C., Behrman, S., Berger, A., Bloomston, M., Callery, M., Christein, J., Falconi, M., Fernandez-Del Castillo, C., Dillhoff, M., Dickson, E., Dixon, E., Fisher, W., House, M., Hughes, S., Kent, T., Malleo, G., Partelli, S., Salem, R., Stauffer, J., Wolfgang, C., Zureikat, A., Vollmer, C.

Publikováno v: In Pancreatology July 2021 21 Supplement 1:S103-S104

Optimal Extent of Lymphadenectomy for Gastric Adenocarcinoma: A 7-Institution Study of the U.S. Gastric Cancer Collaborative

Autor: Randle, Rw, Swords, Ds, Levine, Ea, Fino, Nf, Squires, Mh, Poultsides, G, Fields, Rc, Bloomston, M, Weber, Sm, Pawlik, Tm, Jin, Ldx, Spolverato, G, Schmidt, C, Worhunsky, D, Cho, Cs, Maithel, Sk, Votanopoulos, Ki

The optimal extent of lymphadenectomy in the treatment of gastric adenocarcinoma is debated. We compared gastrectomy outcomes following limited (D1) or extended (D2) lymphadenectomy.Using the multi-institutional US Gastric Cancer Collaborative databa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::967a1aae01c6d2664c91f73e4980ccca
https://europepmc.org/articles/PMC4874863/

Unveiling the microRNA landscape in pancreatic ductal adenocarcinoma patients and cancer cell models.

Autor: Fenu, Grazia¹ (AUTHOR), Griñán-Lisón, Carmen^2,3,4,5 (AUTHOR), Pisano, Andrea¹ (AUTHOR), González-Titos, Aitor^2,3 (AUTHOR), Farace, Cristiano^1,6 (AUTHOR) cristiano.farace@hotmail.it, Fiorito, Giovanni⁷ (AUTHOR), Etzi, Federica¹ (AUTHOR), Perra, Teresa⁸ (AUTHOR), Sabalic, Angela¹ (AUTHOR), Toledo, Belén^3,9 (AUTHOR), Perán, Macarena⁹ (AUTHOR), Solinas, Maria Giuliana¹ (AUTHOR), Porcu, Alberto⁸ (AUTHOR), Marchal, Juan Antonio^2,3,4,10 (AUTHOR) jmarchal@ugr.es, Madeddu, Roberto^1,6 (AUTHOR)

Publikováno v: BMC Cancer. 10/24/2024, Vol. 24 Issue 1, p1-15. 15p.